Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 393

Bankrupt Jumio identifies Centana as buyer

The assets of Jumio, an online credentials authentication company that had raised $35m from backers including Citi, are set to be acquired by growth equity firm Centana.

May 10, 2016

Jasper aims for TargetingMantra acquisition

One97 has exited marketing technology developer TargetingMantra following its acquisition by Jasper Infotech, the owner of online marketplace Snapdeal.

May 10, 2016

NantHealth diagnoses public markets potential

The diagnostics technology developer, backed by Allscripts, Celgene and Blackberry, has filed for an initial public offering provisionally sized at up to $92m.

May 10, 2016

URX links itself to Pinterest

Deep linking technology producer URX has been acquired by social media platform Pinterest after raising $15m from investors including GV and CyberAgent.

May 6, 2016

Viamet shows mettle in second IPO attempt

Viamet, which has raised about $170m from backers including Novartis, Eli Lilly and Astellas, is set to raise up to $91m, after withdrawing its last IPO filing in 2014.

May 5, 2016

Formlabs marks out Pinshape for acquisition

Pinshape, which operates a 3D printing designs marketplace, had raised $850,000 in seed funding from investors including internet company DeNA.

May 5, 2016

Ecomachines sells on Recycling Technologies stake

Ecomachines sells its shares in Warwick spinout Recycling Technologies to an undisclosed private investor.

May 4, 2016

Vimeo subscribes to VHX acquisition

Comcast, William Morris Endeavor and Bedrocket Media Ventures have exited video distribution platform VHX through an acquisition by video streaming service Vimeo.

May 3, 2016

Intellia edits IPO terms

The gene editing company expects to raise up to $90m, while Novartis and Regeneron are set to invest $55m through private placements.

Apr 29, 2016

AbbVie breathes in Stemcentrx in $9.8bn deal

Fidelity-backed Stemcentrx, which emerged from stealth in September at a $5bn valuation, will be acquired for $5.8bn in cash and stock, and up to $4bn in milestone payments.

Apr 29, 2016
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here